Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia

Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia

10.1038/s41388-018-0526-3

Saved in:

Bibliographic Details
Main Authors:	Chong, Phyllis SY, Zhou, Jianbiao, Chooi, Jing-Yuan, Chan, Zit-Liang, Toh, Sabrina Hui Min, Tan, Tuan Zea, Wee, Sheena, Gunaratne, Jayantha, Zeng, Qi, Chng, Wee-Joo
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	NATURE PUBLISHING GROUP 2020
Subjects:	Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology Cell Biology Genetics & Heredity SIGNALING PATHWAY ASSOCIATION
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/166529
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 Phosphatase
by: Wang, Haihe, et al.
Published: (2021)

Targeting of the MNK-eIF4E axis in blast crisis Chronic myeloid leukemia inhibits leukemia stem cell function
by: Lim, S., et al.
Published: (2014)

A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase
by: Zhou, J, et al.
Published: (2020)

PRL-3 phosphatase and cancer metastasis
by: Al-Aidaroos, A.Q.O., et al.
Published: (2014)

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia
by: Zhou J., et al.
Published: (2018)

POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
by: Muhammad Bakhait Rahmat, et al.
Published: (2019)

RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
by: Koschut, David, et al.
Published: (2022)

Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group
by: Chanswangphuwana C.
Published: (2023)

The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/beta-catenin signaling (vol 12, 173, 2020)
by: Tao, Chunfang, et al.
Published: (2023)

LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML
by: Zhou, Jianbiao, et al.
Published: (2021)

Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis
by: Bai, Y, et al.
Published: (2020)

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.
by: Zhou, Jianbiao, et al.
Published: (2022)

Natural compounds as antagonists of canonical Wnt/β-catenin signaling
by: Leow, P.C., et al.
Published: (2014)

GLOBAL DISCOVERY OF DYSREGULATED PROTEIN EXPRESSION AND PHOSPHORYLATION NETWORKS IDENTIFIED LEO1 AS A KEY TARGET OF PRL-3 PHOSPHATASE IN LEUKEMOGENESIS
by: CHONG SHU YUN, PHYLLIS
Published: (2015)

Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry
by: Chanswangphuwana C.
Published: (2023)

Leukemia inhibitory factor (LIF) regulates JAK/STAT and canonical Wnt/β-catenin signaling pathways during murine embryo implantation.
by: Yee, Li Xuan.
Published: (2013)

Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry
by: Chantiya Chanswangphuwana, et al.
Published: (2022)

New mutations of the ID1 gene in acute myeloid leukemia patients
by: Chintana Tochareontanaphol, et al.
Published: (2018)

Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
by: Guo, Ke, et al.
Published: (2013)

Diagnosis and monitoring of chronic myeloid leukemia: Chiang Mai university experience
by: Adisak Tantiworawit, et al.
Published: (2018)

Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia
by: Pakpoom Phoompoung, et al.
Published: (2022)

WT1 mutations and polymorphisms in Southeast Asian acute myeloid leukemia
by: Darat Lauhakirti, et al.
Published: (2018)

Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia
by: Fei Yang, et al.
Published: (2020)

Multiplex RT-PCR assay for detection of common fusion transcripts in acute lymphoblastic leukemia and chronic myeloid leukemia cases
by: Nittaya Limsuwanachot, et al.
Published: (2018)

THE SIGNALING AND REGULATION OF METASTASIS-ASSOCIATED PHOSPHATASE PRL-3 IN HUMAN CANCER CELLS
by: ABDUL QADER OMER AL-AIDAROOS
Published: (2012)

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study
by: Philippe Rousselot, et al.
Published: (2018)

Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone
by: Emmanuelle Verger, et al.
Published: (2018)

Computational analysis and characterization of dysregulated chromatin interactions and RNA biology in acute myeloid leukemia
by: Kong, Lingshi
Published: (2022)

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition
by: Kran Suknuntha, et al.
Published: (2021)

SWATH-Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G-CSFR Signaling
by: Pankaj Dwivedi, et al.
Published: (2020)

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
by: Jin, S, et al.
Published: (2020)

Phosphatase PRL-3 is a direct regulatory target of TGFb in colon cancer metastasis
by: Jiang, Y, et al.
Published: (2020)

EGF Inhibits Wnt/β-Catenin-Induced Osteoblast Differentiation by Promoting β-Catenin Degradation
by: Kanitsak Boonanantanasarn, et al.
Published: (2018)

IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma
by: Chong, Phyllis SY, et al.
Published: (2020)

Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone
by: Emmanuelle Verger, et al.
Published: (2018)

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
by: Park, J.E., et al.
Published: (2014)

Simvastatin enhances the efficacy of Bcr-Abl tyrosine kinase inhibitor nilotinib in chronic myeloid leukemia.
by: Koh, Yanqing.
Published: (2011)

Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients
by: Pimjai Niparuck, et al.
Published: (2018)

NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28B
by: Zhou, Jianbiao, et al.
Published: (2022)

Regulation of chromatin interactions to the MYC oncogene by long non-coding RNA PVT1 in acute myeloid leukemia cell lines
by: Nur Zahwah Asa'ad Sameer Bagharib
Published: (2018)